Litigation Capital Management Ltd
31 July 2026
31 July 2026
Litigation Capital Management Limited
("LCM" or the "Company")
Covenant Waiver Extension
Litigation Capital Management Limited ("LCM"), an alternative asset manager specialising in dispute financing solutions internationally, announces that the debt covenant waiver from Northleaf that was due to expire on 31 July 2026 has been extended to 31 August 2026. During the extended waiver period the interest on the loan remains increased by 2.00% per annum consistent with the initial waiver. There is no additional one-time waiver fee in relation to this extension.
The Strategic Review that was first announced on 15 September 2025 continues to progress and the waiver extension is reflective of Northleaf's ongoing support while LCM works towards a long-term resolution of its capital position. Management will provide an update on the progress of the Strategic Review in due course.
Enquiries
|
Litigation Capital Management |
|
|
Patrick Moloney, Chief Executive Officer David Collins, Chief Financial Officer |
|
|
Cavendish (Nomad and Broker) |
Tel: 020 7220 0500 |
|
Jonny Franklin-Adams and Isaac Hooper (Corporate Finance) Ella Bedford (Corporate Broking) |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.